Autism Disorder and Treatment Market Highlights:
Growing burden of autism in western countries has majorly contributed to the growth of the market and is likely to increase due to growing number of cases of autism around the globe in the coming years which will also boost the market growth during the forecast period. Environmental and genetic factors are major factors which have majorly increased the prevalence of autism disorder, and it is expected to increase in the coming decade due to various factors such as poor nutritional conditions of children and adolescents, increasing environmental toxins and increasing prenatal and perinatal maternal stress.
According to a recent epidemiological study, it has been observed that around 87% of the ASD cases are from Europe, Japan, and North America, while only 10% of the world’s children live in these countries. Moreover, the Centers for Disease Control’s (CDC) Autism and Developmental Disabilities Monitoring (ADDM) society stated that approximately 1 in 68 children in the United States was identified with an Autism Spectrum Disorder (ASD) in 2016.
Request and Read Exclusive Sample Report @ https://www.marketresearchfuture.com/sample_request/1605
Major Players in the Autism Disorder & Treatment Market Research Report
Pfizer Inc.,
Eli Lilly and Company,
Allergan, Merck & CO Inc.,
Teva Pharmaceutical Industries Ltd.,
Consern Pharma Private Limited,
Novartis AG,
Johnson & Johnson Services, Inc.
Bristol-Myers Squibb and Otsuka Holdings Co Ltd,
Coronis Partners Ltd.,
Curemark LLC,
Heptares Therapeutics Limited,
Intra-Cellular Therapies Inc and Saniona AB.
The Global Autism Disorder and Treatment Market has been identified as one of the rapidly growing industries, owing to rising prevalence of autism and Pervasive Developmental Disorder (PDD) and raising awareness about autism among the patient population. Autism disorder and treatment is observed as one of the significantly growing markets in the healthcare sector because of initiatives by the government of various nations and expected approvals of various off-label treatment therapies by the Food and Drug Association (FDA). With the upsurge in the market, there are some hindrances faced by the market such as a weak pipeline of drugs for autism disorder and unknown etiology and pathophysiology of ASD.
Segmentation
The Global Autism Disorder & Treatment Market is segmented by type, treatment type, and drugs. On the basis of type, it is segmented into Asperger Syndrome, Pervasive Developmental Disorder, others. On the basis of treatment type, it is segmented into ABA (applied behavioral analysis), hyperbaric oxygen therapy, chelation therapy, oxytocin therapy and others. On the basis of drugs, it is segmented into SSRIs, anti-convulsant, stimulants, anti-psychotic. Anti-psychotics are further segmented into Abilify (aripiprazole) and Risperidone.
Regional Analysis
The Global Autism Disorder & Treatment Market is segmented into four regions namely the Americas, Europe, Asia Pacific, and the Middle East & Africa, with Americas holding the largest market share followed by Europe. In Americas, North America accounted for the largest market owing to the increasing screening of autism cases in this region. Additionally, the approval and expected launch of the atypical anti-psychotic such as Latuda and Namenda is expected to generate increased sales in the U.S. post-approval. Asia Pacific is expected to be the fastest growing market while the Middle East & Africa exhibit steady and growth during the forecast period. As per the epidemiological studies conducted over the past 50 years have suggested that the prevalence of ASD is increasing globally. Some of the factors responsible for the increasing prevalence are improved awareness, expansion of diagnostic criteria, better diagnostic tools and improved reporting.
Reach to Experts @ https://www.marketresearchfuture.com/enquiry/1605
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future,
Office No. 528, Amanora Chambers,
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
